Cargando…

Bioprocess development for enhanced endoglucanase production by newly isolated bacteria, purification, characterization and in-vitro efficacy as anti-biofilm of Pseudomonas aeruginosa

Endoglucanase producing bacteria were isolated from Egyptian soils and the most active bacterial strain was identified as Bacillus subtilis strain Fatma/1. Plackett–Burman statistical design was carried out to assess the effect of seven process variables on endoglucanase production. Carboxymethyl ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibrahim, Atef M., Hamouda, Ragaa A., El-Naggar, Noura El-Ahmady, Al-Shakankery, Fatma M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105381/
https://www.ncbi.nlm.nih.gov/pubmed/33963217
http://dx.doi.org/10.1038/s41598-021-87901-9
_version_ 1783689599612092416
author Ibrahim, Atef M.
Hamouda, Ragaa A.
El-Naggar, Noura El-Ahmady
Al-Shakankery, Fatma M.
author_facet Ibrahim, Atef M.
Hamouda, Ragaa A.
El-Naggar, Noura El-Ahmady
Al-Shakankery, Fatma M.
author_sort Ibrahim, Atef M.
collection PubMed
description Endoglucanase producing bacteria were isolated from Egyptian soils and the most active bacterial strain was identified as Bacillus subtilis strain Fatma/1. Plackett–Burman statistical design was carried out to assess the effect of seven process variables on endoglucanase production. Carboxymethyl cellulose (CMC), yeast extract and peptone were the most significant variables that enhanced the endoglucanase production and thus were selected for further optimization using face-centered central composite design. The highest yield of endoglucanase (32.37 U/mL) was obtained in run no. 9, using 18 g/L CMC, 8 g/L peptone, 7 g/L yeast extract and 0.1 g/L FeSO(4).7H(2)O. The optimized medium showed about eightfold increase in endoglucanase production compared to the unoptimized medium. The produced crude enzyme was further purified by ammonium sulfate precipitation, then DEAE-Sepharose CL6B column. The purified enzyme was shown to have a molecular weight of 37 kDa. The enzyme showed maximum activity at pH 8.0, temperature of 50 °C, incubation time of 60 min. The half-life time (T(1/2)) was 139.53 min at 50 °C, while being 82.67 min at 60 °C. Endoglucanase at concentration of 12 U/mL effectively removed 84.61% of biofilm matrix of Pseudomonas aeruginosa with marked reduction in carbohydrate content of the biofilm from 63.4 to 7.9 μg.
format Online
Article
Text
id pubmed-8105381
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-81053812021-05-10 Bioprocess development for enhanced endoglucanase production by newly isolated bacteria, purification, characterization and in-vitro efficacy as anti-biofilm of Pseudomonas aeruginosa Ibrahim, Atef M. Hamouda, Ragaa A. El-Naggar, Noura El-Ahmady Al-Shakankery, Fatma M. Sci Rep Article Endoglucanase producing bacteria were isolated from Egyptian soils and the most active bacterial strain was identified as Bacillus subtilis strain Fatma/1. Plackett–Burman statistical design was carried out to assess the effect of seven process variables on endoglucanase production. Carboxymethyl cellulose (CMC), yeast extract and peptone were the most significant variables that enhanced the endoglucanase production and thus were selected for further optimization using face-centered central composite design. The highest yield of endoglucanase (32.37 U/mL) was obtained in run no. 9, using 18 g/L CMC, 8 g/L peptone, 7 g/L yeast extract and 0.1 g/L FeSO(4).7H(2)O. The optimized medium showed about eightfold increase in endoglucanase production compared to the unoptimized medium. The produced crude enzyme was further purified by ammonium sulfate precipitation, then DEAE-Sepharose CL6B column. The purified enzyme was shown to have a molecular weight of 37 kDa. The enzyme showed maximum activity at pH 8.0, temperature of 50 °C, incubation time of 60 min. The half-life time (T(1/2)) was 139.53 min at 50 °C, while being 82.67 min at 60 °C. Endoglucanase at concentration of 12 U/mL effectively removed 84.61% of biofilm matrix of Pseudomonas aeruginosa with marked reduction in carbohydrate content of the biofilm from 63.4 to 7.9 μg. Nature Publishing Group UK 2021-05-07 /pmc/articles/PMC8105381/ /pubmed/33963217 http://dx.doi.org/10.1038/s41598-021-87901-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Ibrahim, Atef M.
Hamouda, Ragaa A.
El-Naggar, Noura El-Ahmady
Al-Shakankery, Fatma M.
Bioprocess development for enhanced endoglucanase production by newly isolated bacteria, purification, characterization and in-vitro efficacy as anti-biofilm of Pseudomonas aeruginosa
title Bioprocess development for enhanced endoglucanase production by newly isolated bacteria, purification, characterization and in-vitro efficacy as anti-biofilm of Pseudomonas aeruginosa
title_full Bioprocess development for enhanced endoglucanase production by newly isolated bacteria, purification, characterization and in-vitro efficacy as anti-biofilm of Pseudomonas aeruginosa
title_fullStr Bioprocess development for enhanced endoglucanase production by newly isolated bacteria, purification, characterization and in-vitro efficacy as anti-biofilm of Pseudomonas aeruginosa
title_full_unstemmed Bioprocess development for enhanced endoglucanase production by newly isolated bacteria, purification, characterization and in-vitro efficacy as anti-biofilm of Pseudomonas aeruginosa
title_short Bioprocess development for enhanced endoglucanase production by newly isolated bacteria, purification, characterization and in-vitro efficacy as anti-biofilm of Pseudomonas aeruginosa
title_sort bioprocess development for enhanced endoglucanase production by newly isolated bacteria, purification, characterization and in-vitro efficacy as anti-biofilm of pseudomonas aeruginosa
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105381/
https://www.ncbi.nlm.nih.gov/pubmed/33963217
http://dx.doi.org/10.1038/s41598-021-87901-9
work_keys_str_mv AT ibrahimatefm bioprocessdevelopmentforenhancedendoglucanaseproductionbynewlyisolatedbacteriapurificationcharacterizationandinvitroefficacyasantibiofilmofpseudomonasaeruginosa
AT hamoudaragaaa bioprocessdevelopmentforenhancedendoglucanaseproductionbynewlyisolatedbacteriapurificationcharacterizationandinvitroefficacyasantibiofilmofpseudomonasaeruginosa
AT elnaggarnouraelahmady bioprocessdevelopmentforenhancedendoglucanaseproductionbynewlyisolatedbacteriapurificationcharacterizationandinvitroefficacyasantibiofilmofpseudomonasaeruginosa
AT alshakankeryfatmam bioprocessdevelopmentforenhancedendoglucanaseproductionbynewlyisolatedbacteriapurificationcharacterizationandinvitroefficacyasantibiofilmofpseudomonasaeruginosa